March 06, 2026 16:15 ET | Source: Crescent Biopharma, Inc. WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma,…
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics,…
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…
SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ -- In a major step forward against Antimicrobial Resistance (AMR), NG…
February 17, 2026 18:22 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BridgeBio…
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE)…
February 02, 2026 16:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- In…
MUMBAI, India, Jan. 24, 2026 /PRNewswire/ -- XED, a globally integrated executive education enterprise, has received in-principle approval from NSE…